Cargando…
Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy
Autores principales: | Fu, Juan, Kim, Young, Kanne, David, Leong, Meredith, Zeng, Qi, Sen, Rupashree, Amstrong, Todd D, Drake, Charles G, Dubensky, Thomas, Pardoll, Drew, Gadkare, Shekhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649318/ http://dx.doi.org/10.1186/2051-1426-3-S2-P268 |
Ejemplares similares
-
Cyclic dinucleotides (CDNs) anti-tumors response by activating DC and NK cell crosstalk
por: Fu, Juan, et al.
Publicado: (2014) -
Mass spectrometric characterization of cyclic dinucleotides (CDNs) in vivo
por: Annibal, Andrea, et al.
Publicado: (2021) -
Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
por: Leong, Meredith, et al.
Publicado: (2013) -
Evolution and challenges of DNS-based CDNs
por: Wang, Zheng, et al.
Publicado: (2018) -
Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
por: Corrales, Leticia, et al.
Publicado: (2014)